J. A. Johnson

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing

J. A. Johnson, Li Gong, Michelle Whirl‐Carrillo et al. · Clinical Pharmacology & Therapeutics · 2011 · 643 citations

Thrombosis, Therapeutic Warfarin Dose, Target Anticoagulation +15

Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy

Stuart A. Scott, Katrin Sangkuhl, E E Gardner et al. · Clinical Pharmacology & Therapeutics · 2011 · 479 citations

Genetics, Cardiovascular Pharmacology, Pharmacotherapy +21

Distribution of Vibrio vulnificus in the Chesapeake Bay

A C Wright, Russell T. Hill, J. A. Johnson et al. · Applied and Environmental Microbiology · 1996 · 279 citations · Full text

Risk Factors for Imipenem-Resistant Pseudomonas aeruginosa among Hospitalized Patients

Anthony Harris, David L. Smith, J. A. Johnson et al. · Clinical Infectious Diseases · 2002 · 186 citations · Full text

Antimicrobial Susceptibility, Health Sciences, Antibiotics +13

Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences

J. A. Johnson, C A Salles, Pinaki Panigrahi et al. · Infection and Immunity · 1994 · 162 citations · Full text

Normal Human Serum, Medical Microbiology, Important Differences +13